A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma - Concepedia

Concepedia

Publication | Open Access

A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

DOI Full Paper Access

51

Citations

32

References

2017

Year

Stina Wichert, Gunnar Juliusson, Åsa Johansson, Elisabeth Sonesson, Ingrid Teige, Anna Teige Wickenberg, Björn Frendéus, Magnus Korsgren, Markus Hansson

Abstract

ClinicalTrials.gov Identifier: NCT01838369.

References

	Year	Citations

Page 1